Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies

Predominantly antibody deficiencies (PADs) are inborn disorders characterized by immune dysregulation and increased susceptibility to infections. Response to vaccination, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may be impaired in these patients, and studies on respons...

Full description

Bibliographic Details
Main Authors: Zane Lucane, Baiba Slisere, Gita Gersone, Sindija Papirte, Linda Gailite, Peteris Tretjakovs, Natalja Kurjane
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/5/1146
_version_ 1797598061023723520
author Zane Lucane
Baiba Slisere
Gita Gersone
Sindija Papirte
Linda Gailite
Peteris Tretjakovs
Natalja Kurjane
author_facet Zane Lucane
Baiba Slisere
Gita Gersone
Sindija Papirte
Linda Gailite
Peteris Tretjakovs
Natalja Kurjane
author_sort Zane Lucane
collection DOAJ
description Predominantly antibody deficiencies (PADs) are inborn disorders characterized by immune dysregulation and increased susceptibility to infections. Response to vaccination, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may be impaired in these patients, and studies on responsiveness correlates, including cytokine signatures to antigen stimulation, are sparse. In this study, we aimed to describe the spike-specific cytokine response following whole-blood stimulation with SARS-CoV-2 spike peptides in patients with PAD (<i>n</i> = 16 with common variable immunodeficiency and <i>n</i> = 15 with selective IgA deficiency) and its relationship with the occurrence of coronavirus disease 2019 (COVID-19) during up to 10-month follow-up period. Spike-induced antibody and cytokine production was measured using ELISA (anti-spike IgG, IFN-γ) and xMAP technology (interleukin-1β (IL-1β), IL-4, IL-6, IL-10, IL-15, IL-17A, IL-21, TNF-α, TGF-β1). No difference was found in the production of cytokines between patients with PAD and controls. Anti-spike IgG and cytokine levels did not predict contraction of COVID-19. The only cytokine that distinguished between vaccinated and naturally infected unvaccinated PAD patients was IFN-γ (median 0.64 (IQR = 1.08) in vaccinated vs. 0.10 (IQR = 0.28) in unvaccinated). This study describes the spike-specific cytokine response to SARS-CoV-2 antigens, which is not predictive of contracting COVID-19 during the follow-up.
first_indexed 2024-03-11T03:14:04Z
format Article
id doaj.art-09a24991391945b798468a9549805e11
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-11T03:14:04Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-09a24991391945b798468a9549805e112023-11-18T03:39:39ZengMDPI AGViruses1999-49152023-05-01155114610.3390/v15051146Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody DeficienciesZane Lucane0Baiba Slisere1Gita Gersone2Sindija Papirte3Linda Gailite4Peteris Tretjakovs5Natalja Kurjane6Department of Biology and Microbiology, Riga Stradins University, LV-1007 Riga, LatviaThe Joint Laboratory, Pauls Stradins Clinical University Hospital, LV-1002 Riga, LatviaDepartment of Human Physiology and Biochemistry, Riga Stradins University, LV-1007 Riga, LatviaFaculty of Medicine, Riga Stradins University, LV-1007 Riga, LatviaScientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, LatviaDepartment of Human Physiology and Biochemistry, Riga Stradins University, LV-1007 Riga, LatviaDepartment of Biology and Microbiology, Riga Stradins University, LV-1007 Riga, LatviaPredominantly antibody deficiencies (PADs) are inborn disorders characterized by immune dysregulation and increased susceptibility to infections. Response to vaccination, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may be impaired in these patients, and studies on responsiveness correlates, including cytokine signatures to antigen stimulation, are sparse. In this study, we aimed to describe the spike-specific cytokine response following whole-blood stimulation with SARS-CoV-2 spike peptides in patients with PAD (<i>n</i> = 16 with common variable immunodeficiency and <i>n</i> = 15 with selective IgA deficiency) and its relationship with the occurrence of coronavirus disease 2019 (COVID-19) during up to 10-month follow-up period. Spike-induced antibody and cytokine production was measured using ELISA (anti-spike IgG, IFN-γ) and xMAP technology (interleukin-1β (IL-1β), IL-4, IL-6, IL-10, IL-15, IL-17A, IL-21, TNF-α, TGF-β1). No difference was found in the production of cytokines between patients with PAD and controls. Anti-spike IgG and cytokine levels did not predict contraction of COVID-19. The only cytokine that distinguished between vaccinated and naturally infected unvaccinated PAD patients was IFN-γ (median 0.64 (IQR = 1.08) in vaccinated vs. 0.10 (IQR = 0.28) in unvaccinated). This study describes the spike-specific cytokine response to SARS-CoV-2 antigens, which is not predictive of contracting COVID-19 during the follow-up.https://www.mdpi.com/1999-4915/15/5/1146antibody deficiencycommon variable immunodeficiencyselective IgA deficiencySARS-CoV-2COVID-19cytokine
spellingShingle Zane Lucane
Baiba Slisere
Gita Gersone
Sindija Papirte
Linda Gailite
Peteris Tretjakovs
Natalja Kurjane
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
Viruses
antibody deficiency
common variable immunodeficiency
selective IgA deficiency
SARS-CoV-2
COVID-19
cytokine
title Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
title_full Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
title_fullStr Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
title_full_unstemmed Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
title_short Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
title_sort cytokine response following sars cov 2 antigen stimulation in patients with predominantly antibody deficiencies
topic antibody deficiency
common variable immunodeficiency
selective IgA deficiency
SARS-CoV-2
COVID-19
cytokine
url https://www.mdpi.com/1999-4915/15/5/1146
work_keys_str_mv AT zanelucane cytokineresponsefollowingsarscov2antigenstimulationinpatientswithpredominantlyantibodydeficiencies
AT baibaslisere cytokineresponsefollowingsarscov2antigenstimulationinpatientswithpredominantlyantibodydeficiencies
AT gitagersone cytokineresponsefollowingsarscov2antigenstimulationinpatientswithpredominantlyantibodydeficiencies
AT sindijapapirte cytokineresponsefollowingsarscov2antigenstimulationinpatientswithpredominantlyantibodydeficiencies
AT lindagailite cytokineresponsefollowingsarscov2antigenstimulationinpatientswithpredominantlyantibodydeficiencies
AT peteristretjakovs cytokineresponsefollowingsarscov2antigenstimulationinpatientswithpredominantlyantibodydeficiencies
AT nataljakurjane cytokineresponsefollowingsarscov2antigenstimulationinpatientswithpredominantlyantibodydeficiencies